Morgan Stanley Direct Lending Fund — Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports an unregistered equity issuance by Morgan Stanley Direct Lending Fund, a Delaware company. The capital drawdown notice was delivered on July 30, 2020, and the sale closed on August 11, 2020. The filing was signed on August 13, 2020.
Transaction and Key Financial Metrics
- The Company sold approximately 2,003,005 shares of common stock, par value $0.001 per share.
- Aggregate offering price: $40.0 million.
- Implied offering price: approximately $19.97 per share, based on the reported aggregate proceeds and share count.
- The transaction represents a capital drawdown under existing subscription agreements and is not described as a public offering.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, net asset value, or other operating-performance metrics.
Material Changes Versus Prior Comparable Period
The filing does not provide a prior-period comparison. The material event reported is the receipt of approximately $40.0 million in equity capital through the issuance of common stock.
Terms, Outlook, and Risks
- Stockholders are required to fund drawdowns to purchase shares up to their respective capital commitments on an as-needed basis.
- The Company must provide stockholders with at least eight business days’ prior notice of a drawdown.
- The issuance was made in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act and Regulation D.
- The Company relied in part on stockholder representations that each investor was an accredited investor under Regulation D.
- The filing provides no management guidance, investment outlook, contingency disclosure, or discussion of use of proceeds.
Important Facts for Investors to Verify
- Verify the final number of shares issued and the exact per-share purchase price, as the filing reports the share count as approximately 2,003,005.
- Review the applicable subscription agreements and each stockholder’s remaining capital commitment.
- Confirm the intended use of the $40.0 million in proceeds and the effect on the Company’s investment capacity and liquidity.
- Assess the risks associated with the private, unregistered issuance and the accredited-investor representations.